Hainan Hualon Pharmaceutical Co.,Ltd

Hainan Hualon Pharmaceutical Co.,Ltd is a national torch program key high-tech enterprise, Hainan headquarters economic enterprises. It is mainly engaged in the R&D, production and sales of chemical raw materials and preparations. The company was listed on National Equities Exchange and Quotations in November 2015, stock code: 834298.

Hualon is located in Hainan Haikou, now Hainan is developing into a Free trade Port by the government, which means it will align itself with high-level global economic and trade rules, and become a convenient business environment. The company has two production bases and three subsidiaries in Hainan, which are Hainan Hualon Healthcare Industry Co., Ltd. Yindasun Medical Device Co., Ltd. And Yindakang(Hainan) Medical Equipment Co., Ltd.

The company has a complete production system; it has standard workshops of about 70,000 square meters. The company has six categories of production workshops which including API workshop (sterile API oral API); Powder injection workshop (powder-injection); Lyophilized powder for injection workshop (Lyophilized powder for injection); Oral solid preparation workshop (tablet, capsule, granule, dry suspension); Soft capsule workshop (soft capsule) and External drug use workshop (lotion, solution, ointment, liniment, gel). The company mainly focusing on cardio cerebrovascular, digestive system, gynecological medicine, antipyretic and analgesic products.

The production line is equipped with the both domestic and abroad first-class production equipment, and a batch of modern drug testing instruments. Because of the good hardware facilities and strict GMP management, the products of Hualon are high quality, safe and efficient. The multi-dosage production line enables the company to adapt to the changes in the pharmaceutical market and to produce drugs with different dosage forms at any time to meet the society needs.